Patents by Inventor Christine Reinemann

Christine Reinemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220112499
    Abstract: The present invention relates inter alia to aptamers that specifically bind to Imatinib and methods of using the same.
    Type: Application
    Filed: November 27, 2019
    Publication date: April 14, 2022
    Inventors: Christine REINEMANN, Edward BARNES, David Harry John BUNKA, Arron Craig TOLLEY
  • Publication number: 20220049258
    Abstract: The present invention relates inter alia to aptamers that specifically bind to Irinotecan and methods of using the same.
    Type: Application
    Filed: November 27, 2019
    Publication date: February 17, 2022
    Inventors: Katarzyna BIALAS, Christine REINEMANN, Edward BARNES, David BUNKA, Aaron TOLLEY
  • Patent number: 9903859
    Abstract: The invention relates to a method for identifying aptamers, having the following steps —bringing a mixture of oligonucleotides into contact with an aptamer target structure and binding at least some of the oligonucleotides to the target structure, —separating the oligonucleotides which have been bound to the aptamer target structure from the aptamer target structure and from oligonucleotides that are not bound to the aptamer target structure, —amplifying individual oligonucleotides which were bound to the aptamer target structure in a physically separate manner and producing a plurality of physically separate amplicons, each amplicon predominantly containing one type of oligonucleotides, —specifying a specific marker for a plurality of the physically separate amplicons such that each of the marked amplicons can be uniquely identified using the specified marker of the amplicon, —sequencing oligonucleotides in a plurality of marked amplicons and assigning the marker that is specific for the amplicon to the sequ
    Type: Grant
    Filed: October 25, 2012
    Date of Patent: February 27, 2018
    Assignee: Albert-Ludwigs-Universitaet Freiburg
    Inventors: Guenter Roth, Christine Reinemann, Beate Strehlitz
  • Publication number: 20140303030
    Abstract: The invention relates to a method for identifying aptamers, having the following steps bringing a mixture of oligonucleotides into contact with an aptamer target structure and binding at least some of the oligonucleotides to the target structure, separating the oligonucleotides which have been bound to the aptamer target structure from the aptamer target structure and from oligonucleotides that are not bound to the aptamer target structure, amplifying individual oligonucleotides which were bound to the aptamer target structure in a physically separate manner and producing a plurality of physically separate amplicons, each amplicon predominantly containing one type of oligonucleotides, specifying a specific marker for a plurality of the physically separate amplicons such that each of the marked amplicons can be uniquely identified using the specified marker of the amplicon, sequencing oligonucleotides in a plurality of marked amplicons and assigning the marker that is specific for the amplicon to the sequence
    Type: Application
    Filed: October 25, 2012
    Publication date: October 9, 2014
    Applicant: Albert-Ludwigs-Universitaet Freiburg
    Inventors: Christine Reinemann, Beate Strehlitz